Trovagene has appointed cancer genetics pioneer Alberto Bardelli to its scientific advisory board. Bardelli was among the first researchers to identify mutations in kinase genes linked to colorectal cancer and other tumors. Currently, Bardelli is director of the Laboratory of Molecular Genetics at the Institute for Cancer Research and Treatment and an associate professor in the oncology department at the Torino Medical School in Candiolo, Italy. He also cofounded the biotechnology firm Horizon Discovery Group.
The Personalized Medicine Coalition announced that Daryl Pritchard will be its new vice president of science policy, in charge of promoting the organization's science-related policies and of raising awareness of precision healthcare issues among policymakers, providers, and patients.
Before joining PMC, Pritchard was director of policy research at the National Pharmaceutical Council; director of research programs advocacy and personalized medicine at the Biotechnology Industry Organization; and the director of government affairs for the American Association for Dental Research.